# Molecule

operates the leading DeSci infrastructure for tokenizing biotech intellectual property as IP-NFTs; its Molecule Protocol V2, launched in 2025, integrates these IP-backed tokens with traditional corporate equity as a new "real-world asset" class,…

Source: https://en.bioecon.ru/companies/molecule/
Updated: 2026-08-15

- Country: Switzerland

## Technologies

- [Crowdfunding & retail investment in biotech](https://en.bioecon.ru/technology/crowdfunding-retail-investment-biotech/)